Preclinical evaluation of cilnidipine nanosponges for enhanced oral bioavailability and sustained antihypertensive efficacy
Annales Pharmaceutiques Françaises · 2026-05
DOI: 10.1016/j.pharma.2026.05.010 ↗Kurz gefasst
Fachartikel in der Zeitschrift Annales Pharmaceutiques Françaises, 2026-05. Verfasst von Atul Suryawanshi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutics, Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi) (affiliated to Savitribai Phule Pune University, Pune…. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVE: The present study aimed to evaluate the pharmacokinetic and pharmacodynamic performance of an optimized Cilnidipine-loaded nanosponge (CIL-NS) for oral administration and to compare its bioavailability with a conventional marketed CIL tablet formulation. MATERIALS AND METHODS: CIL-NS were administered orally to male wistar rats at a dose equivalent to 10mg/kg and compared with a marketed CIL tablet suspension (Cilacar®). Plasma drug concentrations were quantified and analyzed using non-compartmental and compartmental pharmacokinetic models. Pharmacodynamic efficacy was assessed using the L-NAME-induced hypertensive rat model. RESULTS: The CIL-NS demonstrated significantly greater systemic exposure than the conventional tablet. CIL-NS achieved a higher Cmax (892.4±45.2ng/mL) at a shorter Tmax [1(1-2)h] than the tablet (363.6±23.5ng/mL at 2 (1-4)h; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmaceutics, Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi) (affiliated to Savitribai Phule Pune University, Pune, India), 411033 Pune, MS, India.
- Department of Pharmaceutics, Marathwada Mitra Mandal's College of Pharmacy, Thergaon (Kalewadi) (affiliated to Savitribai Phule Pune University, Pune, India), 411033 Pune, MS, India. Electronic address: mukeshparkhi@yah…
Zitieren
APA
Suryawanshi, A., Ratnaparkhi, M., & Shinde, R. (2026). Preclinical evaluation of cilnidipine nanosponges for enhanced oral bioavailability and sustained antihypertensive efficacy. Annales Pharmaceutiques Françaises. https://doi.org/10.1016/j.pharma.2026.05.010
Vancouver
Suryawanshi A, Ratnaparkhi M, Shinde R. Preclinical evaluation of cilnidipine nanosponges for enhanced oral bioavailability and sustained antihypertensive efficacy. Annales Pharmaceutiques Françaises. 2026. doi:10.1016/j.pharma.2026.05.010
BibTeX
@article{Suryawanshi2026,
author = {Suryawanshi, Atul and Ratnaparkhi, Mukesh and Shinde, Rushikesh},
title = {Preclinical evaluation of cilnidipine nanosponges for enhanced oral bioavailability and sustained antihypertensive efficacy},
journal = {Annales Pharmaceutiques Françaises},
year = {2026},
doi = {10.1016/j.pharma.2026.05.010}
}
EUVIMED